NCT01289899View on ClinicalTrials.gov

Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Essential Hypertension
Interventions
DRUG

BR-A-657

120, 360mg or placebo 7days

Sponsors

Collaborators (1)

Covance
All Listed Sponsors
collaborator

Covance

INDUSTRY

lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY